A lapsed streaming deal and the ongoing Paramount-Skydance merger review have left viewers outside the U.S. scrambling for ...

The takeover of Accuidity Capital Management boosts Forge Global's AUM by 20%. Read why I've retained a Buy rating for FRGE ...

India's Glenmark Pharmaceuticals said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie have ...

TAC Security, a global leader in cybersecurity solutions and listed as TAC InfoSec Limited (NSE Emerge: INE0SOY01013), is ...

The antibody, ISB 2001, is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) ...

Under the terms of the agreement, Biocytogen will receive an upfront payment from BeOne Medicines. In addition, Biocytogen is ...

Singapore-headquartered financial technology company Ant International is "seriously considering" stablecoin license ...

Ichnos Glenmark Innovation & AbbVie ink exclusive global licensing agreement for ISB 2001: New York Saturday, July 12, 2025, 12:00 Hrs [IST] IGI Therapeutics SA, a wholly owned su ...

Elanco (ELAN) stock in focus as Australia's Neurizon Therapeutics (PAAFF) enters into a licensing deal with the company for ...

Shares of Glenmark Pharmaceuticals Ltd rose 10% to hit a 52-week high on Friday after the drugmaker’s New York-based ...

Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, providing exclusive ...